COVID-19: One Year On

Pinterest LinkedIn Tumblr +

The Oncology Journal Club Episode 36


In today’s special episode of The Oncology Journal Club podcast, Eva Segelov and Craig Underhill talk to Professor Raina MacIntyre about COVID-19: One Year On.

If you’re not familiar with Raina, she heads the Biosecurity Program at the Kirby Institute – you can read her full bio below.

The episode is packed full of information and frank analysis covering a wide range of topics including lack of PPE and moral injury, the different COVID variants and why vaccination is our only exit strategy.

It’s very refreshing to hear one of the world’s leading pandemic experts speak at such length and share her opinion so freely so we hope you find value in this episode – if so, please share the link with family, friends, colleagues and on your social media channels.

And as you will hear Eva mention, a beautiful portrait of Raina, painted by Karen Black, was considered in this year’s Archibald Prize. We’ve reproduced it here with permission from the Art Gallery of New South Wales.  Congratulations Raina and Karen!

Archibald Prize 2021 finalist
Karen Black
‘Professor Chandini Raina Macintyre’ (detail)
oil on canvas, 152.5 x 117 cm
© the artist Photo: AGNSW, Jenni Carter
Sitter: Chandini Raina Macintyre


This Week’s Team:

Professor Raina MacIntyre

Raina MacIntyre

Professor Raina MacIntyre is NHMRC Principal Research Fellow and Professor of Global Biosecurity. She heads the Biosecurity Program at the Kirby Institute, which conducts research in epidemiology, vaccinology, bioterrorism prevention, mathematical modelling, genetic epidemiology, public health and clinical trials in infectious diseases.

Her research falls under 4 areas: Personal protective equipment, Vaccinology, Epidemic response and emerging infectious diseases, and Bioterrorism prevention. She is a dual-specialist physician with training in epidemiology and modelling. Her research is underpinned by her medical training, vaccine program experience and extensive field outbreak investigation experience.

She is best known for research in the detailed understanding of the transmission dynamics and prevention of infectious diseases, particularly respiratory pathogens such as influenza, tuberculosis, bioterrorism agents and vaccine-preventable infections. She has led the largest body of research internationally on face masks and respirators in health care workers. Her research has been influential in informing guidelines for health workers on PPE.

She is involved in several research studies on COVID-19. She leads Biosecurity in Global Security PLuS and is interested in emerging threats to health security. She also designed and co-convenes a course, Bioterrorism and Health Intelligence, taken by students at UNSW and ASU.

Connect on Twitter: @Globalbiosec

Professor Eva Segelov

Eva Segelov

Professor Eva Segelov is a Medical Oncologist and is Director of Oncology at Monash University and Monash Health, Melbourne, Victoria, previously Senior Medical Oncologist at St Vincent’s Hospital, St Vincent’s Private Hospital and St Vincent’s Clinic and Associate Professor of Medicine, University of New South Wales.

Eva has an interest in academic clinical trials in GI and breast cancer and has been a member of the AGITG since 2003. She has clinical trials expertise, links with national and international trials groups, and extensive experience with adult medical education.

You can find Eva on Twitter here: @profevasegelov

Dr Craig Underhill

Craig Underhill

Dr Craig Underhill completed his Bachelor of Medicine and Surgery in 1987 at Melbourne University. He completed medical oncology training in Melbourne and worked as the Senior Clinical Research Registrar at Guy’s Hospital, London.

In 1998 arrived in Albury-Wodonga and established a medical oncology practice and clinical trials unit which has developed expertise and infrastructure to ensure the initiation of high quality trials. The research Unit lead by Dr Underhill has twice been awarded NSW Premier’s Award for Innovation in Cancer Clinical Trials, the inaugural award in 2009 and then again in 2012.

Dr Underhill chaired a working party that was instrumental in securing $65 million in federal funding for The Albury Wodonga Regional Cancer Centre which opened in September 2016.

Dr Underhill is the VCCC Regional Oncology Lead and advocates for the increased access to clinical trials for regional Victorians and leads the VCCC teletrials program.

You can find Craig on Twitter here: @CraigUnderhill

Rachael Babin

Rachael Babin is Editor-in-Chief of The Oncology Newsletter, Publisher of Oncology News Host of The Oncology Podcast and Producer of The Oncology Journal Club. For regular oncology updates for healthcare professionals, please subscribe to The Oncology Newsletter.

With thanks to Eva Segelov, Craig Underhill, Raina MacIntyre and Graham Knowles.

Connect with us on Twitter @OncologyNewsAus #OJC

Share.

About Author

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.